US Patent 9539249 PPAR gamma agonists for treatment of multiple sclerosis
Patent 9539249 was granted and assigned to InteKrin on January, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+151 characters)
Article
Patent abstract
Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
David Weinstein0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09539249 PPAR gamma agonists for treatment of multiple sclerosis US Patent 9539249 PPAR gamma agonists for treatment of multiple sclerosis
Infobox
Patent Number
095392490
Patent Number
95392490
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
095392490
Date of Patent
January 10, 2017
0Patent Application Number
147071220
Date Filed
May 8, 2015
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09539249 PPAR gamma agonists for treatment of multiple sclerosis
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09539249
Date of patent
January 10, 2017
Patent application number
14707122
Date Filed
May 8, 2015
Patent primary examiner
Find more entities like US Patent 9539249 PPAR gamma agonists for treatment of multiple sclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
